← Eichor
Study identifier: NCT06747000 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Lipoprotein Interactions and Platelet Function in Healthy Individuals and Those With Lipid Disorders

Condition: Lipid Disorders  ·  Sponsor: The Miriam Hospital

PhaseN/A
Planned participants80
Who can joinAll sexes, 18 Years to 69 Years
Healthy volunteersYes

About this study

This study looks at how lipoproteins, which are particles in the blood that transport cholesterol, influence heart and blood vessel health. Beyond just their levels, the way these particles function plays a key role in preventing or contributing to disease. In some conditions, like high cholesterol or diabetes, lipoproteins may not work properly, increasing the risk of clogged arteries and other complications. The investigators aim to study these changes in people with lipid disorders to better understand their impact on blood health and to find new ways to prevent and treat heart disease.

This description comes directly from the study's public registry record.

Talk to the study team

Wenliang Song, MD  ·  4014449851  ·  WSong@brownhealth.org

Daria Salamevich  ·  7343588165  ·  DSalamevich@brownhealth.org

Always discuss trial participation with your own doctor first.

Locations (2)

Brown University Health Lipid ClinicEast Providence, Rhode Island, United StatesRecruiting
Cardiovascular Research CenterProvidence, Rhode Island, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06747000